Movatterモバイル変換


[0]ホーム

URL:


RCSB PDB
234,440 Structures from the PDB
1,068,577 Computed Structure Models (CSM)
  • PDB-101
  • wwPDB
  • EMDataResource
  • NAKB: Nucleic Acid Knowledgebase
  • wwPDB Foundation
  • PDB-IHM Logo

 2EYZ|pdb_00002eyz

CT10-Regulated Kinase isoform II


Experimental Data Snapshot

  • Method: SOLUTION NMR
  • Conformers Calculated: 20 
  • Conformers Submitted: 

wwPDB Validation  3D Report Full Report

Currently 2EYZ does not have a validation slider image.


This is version 1.4 of the entry. See complete history


Literature

Structural basis for the transforming activity of human cancer-related signaling adaptor protein CRK.

Kobashigawa, Y.Sakai, M.Naito, M.Yokochi, M.Kumeta, H.Makino, Y.Ogura, K.Tanaka, S.Inagaki, F.

(2007) Nat Struct Mol Biol 14: 503-510

  • PubMed17515907 Search on PubMed
  • DOI: https://doi.org/10.1038/nsmb1241
  • Primary Citation of Related Structures:  
    2DVJ,2EYV,2EYW,2EYX,2EYY,2EYZ

  • PubMed Abstract: 

    CRKI (SH2-SH3) and CRKII (SH2-SH3-SH3) are splicing isoforms of the oncoprotein CRK that regulate transcription and cytoskeletal reorganization for cell growth and motility by linking tyrosine kinases to small G proteins. CRKI shows substantial transforming activity, whereas the activity of CRKII is low, and phosphorylated CRKII has no biological activity whatsoever. The molecular mechanisms underlying the distinct biological activities of the CRK proteins remain elusive. We determined the solution structures of CRKI, CRKII and phosphorylated CRKII by NMR and identified the molecular mechanism that gives rise to their activities. Results from mutational analysis using rodent 3Y1 fibroblasts were consistent with those from the structural studies. Together, these data suggest that the linker region modulates the binding of CRKII to its targets, thus regulating cell growth and motility.


  • Organizational Affiliation

    Department of Structural Biology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido 060-0810, Japan.

Biological Assembly 1  

 Explore in 3DStructure |Sequence Annotations |Validation Report


Global Symmetry: Asymmetric - C1 
Global Stoichiometry: Monomer - A1 


Find Similar Assemblies

Biological assembly 1 assigned by authors.

PreviousNext

Macromolecule Content

  • Total Structure Weight: 33.88 kDa 
  • Atom Count: 2,394 
  • Modelled Residue Count: 304 
  • Deposited Residue Count: 304 
  • Unique protein chains: 1

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
v-crk sarcoma virus CT10 oncogene homolog isoform a304Homo sapiensMutation(s): 0 
UniProt & NIH Common Fund Data Resources
Find proteins for P46108 (Homo sapiens)
Explore P46108 
Go to UniProtKB:  P46108
PHAROS:  P46108
GTEx:  ENSG00000167193 
Entity Groups 
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP46108
Sequence Annotations
Expand
  • Reference Sequence
Experimental Data & Validation

Experimental Data

  • Method: SOLUTION NMR
  • Conformers Calculated: 20 
  • Conformers Submitted: 

Structure Validation

View Full Validation Report

Currently 2EYZ does not have a validation slider image.



Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2006-11-10
    Type: Initial release
  • Version 1.1: 2008-05-01
    Changes: Version format compliance
  • Version 1.2: 2011-07-13
    Changes: Version format compliance
  • Version 1.3: 2022-03-09
    Changes: Data collection, Database references, Derived calculations
  • Version 1.4: 2024-05-29
    Changes: Data collection

RCSB PDB is hosted by


The Rutgers Artificial Intelligence and Data Science Collaboratory logo
Uiversity of California San Diego logoSan Diego Supercomputer Center logo
University of California San Francisco Logo

RCSB PDB is a member of the


wwPDB
EMDataResource

RCSB PDB Core Operations are funded by theU.S. National Science Foundation (DBI-2321666), theUS Department of Energy (DE-SC0019749), and theNational Cancer Institute,National Institute of Allergy and Infectious Diseases, andNational Institute of General Medical Sciences of theNational Institutes of Health under grant R01GM157729.


[8]ページ先頭

©2009-2025 Movatter.jp